Northrop Grumman has reported a 4% drop in third-quarter 2021 sales due to operational distress caused by Covid-19 induced supply chain challenges.

The company’s sales totalled $8.7bn in the three-month period to 30 September 2021, decreasing by $363m from $9.1bn recorded in the third quarter of 2020.

In addition to supply chain-related challenges, the company attributed the decrease to a tight labour market and an increase in employee leave due to the pandemic.

All its business segments except for Space Systems also recorded a fall in quarterly sales.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

However, Northrop’s transaction adjusted net earnings increased from $986m to $1.06bn on a year-on-year basis.

The company’s total operating income was $1.04bn in Q3 2021, up from $985m in the prior-year quarter. The increase was primarily due to lower unallocated corporate expenses.

Quarterly sales in Aeronautics Systems dropped 6% to $2.73bn in Q3 2021 from $2.91bn in Q3 2021.

Defense Systems recorded a 24% drop in quarterly sales to $1.4bn while Mission Systems’ sales totalled $2.44bn after falling 5% on a year-on-year basis.

The lower sales at Defense Systems and Missions Systems were due to the divestiture of the IT services.

Meanwhile, Space Systems’ sales jumped 22% to $2.68bn.

Northrop Grumman chairman, CEO and president Kathy Warden said: “Our third-quarter results reflect strong program performance and the continued focus on operational excellence by the Northrop Grumman team.

“While we did see some labour-related and supply chain challenges stemming from the Covid-19 pandemic on our operations, we delivered solid organic growth, outstanding segment operating margins and strong transaction-adjusted free cash flow in the quarter.

“We are raising our full-year earnings guidance and continue to expect strong organic sales growth.”